Is QCOM a buy, hold, or sell?
QCOM carries a valuation grade of Avoid. At a trailing P/E of 27.0, the stock trades at a 16% discount to the Technology sector median of 32.0x. Our discounted cash flow model produces an intrinsic range of $104–$289 — implying a -22% margin of safety at the current price of $251.02. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 3.6% earnings surprise. Analyst estimate revisions are trending upward.
What are QCOM's key risk factors?
With a beta of 1.49, QCOM exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -19.9% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 2.0% of total portfolio loss in the worst 5% of months. Net margins stand at 22.3%. Return on equity of 36.1% indicates highly efficient capital allocation. The balance sheet is conservatively leveraged at 56% debt-to-equity.
At 0.56, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 88.5% exceeds realized volatility of 1.0% by 87 points, suggesting options are pricing in elevated risk. Insiders have been net sellers to the tune of $58.2M recently. While routine dispositions are common, the magnitude bears watching. Short interest stands at 5.4% of float, a moderate level.
How does QCOM fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — QCOM carries a beta of 1.49, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, QCOM shows the strongest co-movement with ADI (0.43), MRVL (0.30), TXN (0.27). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The QCOM analysis here is a single node in that larger structure.
For analysis of the structural AI infrastructure capex cycle driving demand for QCOM — see our thematic deep-dive: The $7 Trillion Race: AI Infrastructure as a Decade-Long Investment Cycle.
